These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36765614)

  • 21. Enhancing CD8
    Zhang Y; Kurupati R; Liu L; Zhou XY; Zhang G; Hudaihed A; Filisio F; Giles-Davis W; Xu X; Karakousis GC; Schuchter LM; Xu W; Amaravadi R; Xiao M; Sadek N; Krepler C; Herlyn M; Freeman GJ; Rabinowitz JD; Ertl HCJ
    Cancer Cell; 2017 Sep; 32(3):377-391.e9. PubMed ID: 28898698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
    Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
    Aristin Revilla S; Kranenburg O; Coffer PJ
    Front Immunol; 2022; 13():903564. PubMed ID: 35874729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid metabolic features of T cells in the Tumor Microenvironment.
    Lou W; Gong C; Ye Z; Hu Y; Zhu M; Fang Z; Xu H
    Lipids Health Dis; 2022 Oct; 21(1):94. PubMed ID: 36203151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy.
    Lei J; Yang Y; Lu Z; Pan H; Fang J; Jing B; Chen Y; Yin L
    Biochem Pharmacol; 2022 Aug; 202():115153. PubMed ID: 35750199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of the fittest: Cancer challenges T cell metabolism.
    Franchina DG; He F; Brenner D
    Cancer Lett; 2018 Jan; 412():216-223. PubMed ID: 29074426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma.
    Liu J; Sun B; Guo K; Yang Z; Zhao Y; Gao M; Yin Z; Jiang K; Dong C; Gao Z; Ye M; Liu J; Wang L
    Cancer Gene Ther; 2022 Dec; 29(12):1951-1960. PubMed ID: 35902729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-Presenting Intratumoral B Cells Affect CD4
    Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
    Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of Cbl-b inhibits CD8
    Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function.
    Hwang SM; Awasthi D; Jeong J; Sandoval TA; Chae CS; Ramos Y; Tan C; Falco MM; McBain IT; Mishra B; Ivashkiv LB; Zamarin D; Cantillo E; Chapman-Davis E; Holcomb K; Morales DK; Rodriguez PC; Conejo-Garcia JR; Kaczocha M; Vähärautio A; Song M; Cubillos-Ruiz JR
    Res Sq; 2023 Dec; ():. PubMed ID: 38168227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Regulation of T cell Activity: Implications for Metabolic-Based T-cell Therapies for Cancer.
    Abdesheikhi J; Sedghy F; Mahmoodi M; Fallah H; Ranjkesh M
    Iran Biomed J; 2023 Jan; 27(1):1-14. PubMed ID: 36624636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
    Kazemi MH; Sadri M; Najafi A; Rahimi A; Baghernejadan Z; Khorramdelazad H; Falak R
    Front Immunol; 2022; 13():1018962. PubMed ID: 36389779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD147 regulates antitumor CD8
    Chen Y; Xu J; Wu X; Yao H; Yan Z; Guo T; Wang W; Wang P; Li Y; Yang X; Li H; Bian H; Chen ZN
    Cell Mol Immunol; 2021 Aug; 18(8):1995-2009. PubMed ID: 33177695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.
    Davern M; Donlon NE; O'Connell F; Gaughan C; O'Donovan C; McGrath J; Sheppard AD; Hayes C; King R; Temperley H; MacLean M; Bulter C; Bhardwaj A; Moore J; Donohoe C; Ravi N; Conroy MJ; Reynolds JV; Lysaght J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5377-5395. PubMed ID: 36445478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal-Phenolic Nanomedicines Regulate T-Cell Antitumor Function for Sono-Metabolic Cancer Therapy.
    Yan J; Li W; Tian H; Li B; Yu X; Wang G; Sang W; Dai Y
    ACS Nano; 2023 Aug; 17(15):14667-14677. PubMed ID: 37486249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reprogramming the tumor microenvironment with biotechnology.
    Kim M; Lee NK; Wang CJ; Lim J; Byun MJ; Kim TH; Park W; Park DH; Kim SN; Park CG
    Biomater Res; 2023 Jan; 27(1):5. PubMed ID: 36721212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.
    Pan Y; Tian T; Park CO; Lofftus SY; Mei S; Liu X; Luo C; O'Malley JT; Gehad A; Teague JE; Divito SJ; Fuhlbrigge R; Puigserver P; Krueger JG; Hotamisligil GS; Clark RA; Kupper TS
    Nature; 2017 Mar; 543(7644):252-256. PubMed ID: 28219080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
    Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
    J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling.
    Jin J; Zhao Q; Wei Z; Chen K; Su Y; Hu X; Peng X
    Cell Biosci; 2023 Oct; 13(1):189. PubMed ID: 37828561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy.
    Dong X; Xia S; Du S; Zhu MH; Lai X; Yao SQ; Chen HZ; Fang C
    ACS Cent Sci; 2023 Oct; 9(10):1864-1893. PubMed ID: 37901179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.